SAHA, an HDAC inhibitor, overcomes erlotinib resistance in human pancreatic cancer cells by modulating E-cadherin.
Park SJ, Kim SM, Moon JH, Kim JH, Shin JS, Hong SW, Shin YJ, Lee DH, Lee EY, Hwang IY, Kim JE, Kim KP, Hong YS, Lee WK, Choi EK, Lee JS, Jin DH, Kim TW.
Park SJ, et al. Among authors: lee dh, lee ey, lee wk, lee js.
Tumour Biol. 2016 Apr;37(4):4323-30. doi: 10.1007/s13277-015-4216-2. Epub 2015 Oct 22.
Tumour Biol. 2016.
PMID: 26493999